Everolimus-Eluting Platinum Chromium Coronary Stent System
A Meaningful Step Forward in Stent Technology
The SYNERGY BP Stent is the first and only FDA-approved drug-eluting stent with abluminal bioabsorbable polymer coating available in the U.S. It was designed to address the challenges associated with permanent polymer stents such as inflammation, neoatherosclerosis and late stent thrombosis.
The SYNERGY BP Stent provides synchronous drug elution and polymer absorption; the polymer is absorbed shortly after the drug elution is complete at 3-months, providing rapid healing and freedom from long-term polymer exposure. Learn more
Watch Video: EVOLVE Short DAPT Trial Enrollment Complete
SYNERGY BP Stent Short DAPT Data
The SYNERGY BP Stent showed superior results versus BMS in elderly patients that received a shortened DAPT* regimen in the SENIOR Trial. View the data